Session Descriptions
Monday, June 26, 2017 | 9:00 am - 10:15 am
The opioid epidemic is affecting the Commonwealth, much like it is impacting states across the country. The number of overdose deaths continues to rise, and has increased from 2,689 in 2014, to 3,505 in 2015, up to4,812 in 2016, a 78.5 percent increase in drug deaths in just three years (Pennsylvania Coroners Association). Pennsylvania is fighting back with a concerted state effort in the areas of prevention, intervention, treatment and recovery support. Jennifer Smith, acting secretary of the Pennsylvania Department of Drug and Alcohol Programs, will share what the state is doing to battle the opioid epidemic in Pennsylvania.
Upon completion of this session, attendees will be able to:
Upon completion of this session, attendees will be able to:
- Identify two recent changes in the Substance Use Disorder (SUD) landscape
- List three commonwealth projects to address the epidemic
- Identify at least two next steps for continued action
- Please update the registration page to below
Monday, June 26, 2017 | 10:45 am - 12:15 pm
Addiction treatment professionals and the medical community, particularly within pain medicine, do not always have the best of relations. Yet to effectively combat the opioid epidemic, these professionals need to understand how to work together for the good of the communities they serve. With experience in both worlds, Gregory Hobelmann, MD, will explain why physicians have turned to opiates for pain management, as well as address myths about their prescribing practices. In this session, he will share how addiction professionals can better work with the medical community to improve care for patients. He will highlight how vocabulary barriers, misconceptions, and professional and personal barriers have prevented effective care integration for patients in pain and suffering from addiction. Attendees will discover why it is essential that these two groups find common ground and points of discussion if the opioid epidemic is to be effectively addressed.
Upon completion of this session, attendees will be able to:
- Briefly explain how opioids became over utilized and the consequences of overutilization.
- Address myths related to pain management physicians' prescribing of opiates.
- Share practices to collaborate more effectively with the medical and pain medicine community to help patients with pain and addiction.
Monday, June 26, 2017 | 1:30 pm - 3:00 pm
Treatment of addictive disorders and specifically Opioid Use Disorders continues to change as we understand more about the neurobiology of addiction. The use of Medication-Assisted Treatment (MAT) is something that requires education at many levels as it is often thought of as simply drug substitution. Medications used in addition to therapy can assist in sustaining recovery in some people with addiction. As with all medications, the right medication for the right patient is so important and often difficult in those who have addictive disorders. The goal of MAT is to improve patient survival, increase retention in treatment and assist patients in recovery so they have the ability to live a self -directed life. In this session, we will discuss MAT at length.
Upon completion of this session, attendees will be able to:
- Identify the medications used in medication-assisted treatment
- Understand the role of medication- assisted treatment
- Understand how to present MAT to their patients or refer for treatment/MAT
Monday, June 26, 2017 | 3:30 pm - 5:00 pm
Drug overdoses now outnumber motor vehicle accidents as the number one cause of accidental death in the United States, with prescription opioids as the most common cause of drug overdose. The re-emergence of heroin and fentanyl derivatives as popular drugs of choice and causes of overdose can be linked to prescription opioid use. This presentation will trace the history of opioid use through the 20th Century with respect to the management of chronic, noncancer related pain. Data will be presented regarding opioid prescription rates and overdose rates. The linkage between prescription opioids and “street” opioids such as heroin and fentanyl and its derivatives will also be discussed. The Centers for Disease Control and Prevention guidelines for the management of chronic pain will be reviewed as well as other interventions by regulatory agencies.
Upon completion of this session, attendees will be able to:
- Summarize the events leading up to the current epidemic of opioid use for chronic pain.
- Describe multiple nonpharmacologic and nonopioid interventions for the management of chronic pain.
- Discuss important safety provisions when using opioid medications to treat chronic pain.
P05 - Battle Behind Bars: Impact of the Opioid Epidemic on the Incarcerated Population and Strategies to Address It (1.0 CE)
Tuesday, June 27, 2017 | 8:30 am - 9:30 am
In 2015, over 27 million people in the United States used illicit drugs or misused prescription drugs, costing over $400 billion annually in crime, health and lost productivity. Among the incarcerated population, drug overdose is the leading cause of death post-release. The U.S. has the highest rate of incarceration in the world (937 per 100,000 adults). Nearly one-third of heroin users pass through correctional facilities annually. Few receive medications for opioid use disorder during incarceration, and relapse rates and overdose deaths upon release are tragically high (nearly three-quarters relapse to heroin use within 3 months of release). New York City has the nation’s second-largest jail system, and over half experience substance use issues. Rikers Island is the nation’s first and largest opioid treatment program. This session will describe the scope of the opioid use problem in the United States and in the city’s jails like Rikers, current evidence-based treatment and recovery programs, as well as strategies moving forward..
Upon completion of this session, attendees will be able to:
- Identify addiction as a chronic medical disease, a disease of the brain, where relapse is expected.
- Learn to identify evidenced based practices and implement them with fidelity.
- Recognize how addiction impacts the incarcerated population and to identify stigma as a barrier to care for individuals with addiction
P06 - Implementing Evidenced-Based Practices and Measurement Based Care in Addiction Treatment (1.50 CE)
Tuesday, June 27, 2017 | 10:00am - 11:30 am
Deni Carise, PhD
The United States is in the midst an addiction crisis. To address this national emergency, healthcare professionals nationwide must adopt strategies proven to combat substance use in their patients. The Institute of Medicine has called for greater development and implementation of “evidence-based practices” (EBPs) but ensuring adequate adherence and competence in clinical delivery of these practices has proven challenging. The literature shows that Measurement-Based Care (MBC)—the practice of basing clinical care on patient data and feedback collected throughout treatment—is effective in treating addiction, yet it is grossly underused and misunderstood as a standard of care in substance use disorder treatment. The field of addiction treatment has suffered from the lack of any agreed standards whilst coming under increasing pressure to demonstrate effectiveness and be more accountable to justify costs. As the industry faces its most disruptive transformation in its history faith in the way things ‘have always been done’ must be replaced by science. Addiction treatment providers who want to survive and thrive will have to join this revolution in data aggregation, outcome measurement, continuums of care and accountability. Addiction professionals and healthcare facilities nationwide need to understand MBC and implement its use at all levels of treatment. The Joint Commission will require all behavioral health facilities to practice MBC as part of its accreditation process from 2018. There will also be guidance on how practioners and treatment centers can adopt EBPs and MBC to be compliant and to ensure they deliver quality treatment.
Upon completion of this session, attendees will be able to:
The United States is in the midst an addiction crisis. To address this national emergency, healthcare professionals nationwide must adopt strategies proven to combat substance use in their patients. The Institute of Medicine has called for greater development and implementation of “evidence-based practices” (EBPs) but ensuring adequate adherence and competence in clinical delivery of these practices has proven challenging. The literature shows that Measurement-Based Care (MBC)—the practice of basing clinical care on patient data and feedback collected throughout treatment—is effective in treating addiction, yet it is grossly underused and misunderstood as a standard of care in substance use disorder treatment. The field of addiction treatment has suffered from the lack of any agreed standards whilst coming under increasing pressure to demonstrate effectiveness and be more accountable to justify costs. As the industry faces its most disruptive transformation in its history faith in the way things ‘have always been done’ must be replaced by science. Addiction treatment providers who want to survive and thrive will have to join this revolution in data aggregation, outcome measurement, continuums of care and accountability. Addiction professionals and healthcare facilities nationwide need to understand MBC and implement its use at all levels of treatment. The Joint Commission will require all behavioral health facilities to practice MBC as part of its accreditation process from 2018. There will also be guidance on how practioners and treatment centers can adopt EBPs and MBC to be compliant and to ensure they deliver quality treatment.
Upon completion of this session, attendees will be able to:
- Define the meaning of Measurement-Based Care (MBC)
- Learn to identify evidenced based practices and impellent them with fidelity
- Describe potential tools and instruments and curriculum that can be used for EBP and MBC in the behavioral health field
Tuesday, June 27, 2017 | 12:45 pm - 2:15 pm
ACT (Acceptance and Commitment Therapy), introduced by Steven Hayes, PhD, and popularized by Russell Harris, MD, has become a valuable psychological treatment modality for many clinical presentations. This presentation is a review of the origins of ACT, its six core principles for the promotion of "psychological flexibility," and its specific value in the treatment of addictions, with a specific focus citing its efficacy in Opioid Use Disorder.
Upon completion of this session, attendees will be able to:
- Apply the ACT approach for promoting "psychological flexibility"
- Cite the evidence in the literature supporting ACT in Opioid Use Disorder
- Integrate ACT and 12-Step recovery
Tuesday, June 27, 2017 | 2:30 pm - 3:30 pm
Moderator: Doug Edwards
Panelists:
The opioid crisis is being addressed at multiple levels across the country. Many initiatives are just getting off the ground, with new therapies, coalitions, and strategies beginning to make a difference, although the research and data collection process are still being evaluated. The Summit has brought together four experts to share what they’re excited about, what they’re following, and what they’re exploring to make a difference in their patients’ lives and their communities. Each presenter will provide a brief overview of what they see as promising as well as field questions from the audience.
Upon attending this session, attendees will be able to:
- Identify new and promising techniques and/or strategies reducing the impact of the opioid crisis
- Discuss why these have the potential to improve patients’ lives and communities
- Learn how to stay engaged in these promising areas as more data and research are released
Tuesday, June 27, 2017 | 3:30 pm - 5:00 pm
Using a systems perspective and a strength-based model, this workshop will focus on the impact of addiction on the family, strategies for individual and family intervention, and suggestions to facilitate family transitions and recovery. This session will include additional topics, using family rituals to facilitate change, helping family members to utilize emotional, social and moral intelligences to encourage recovery, developing a family continuing care plan, and an appreciation for gender differences in the addiction process and in recovery.
Upon completion of this session, attendees will be able to:
- Identify a family systems model and how it applies to addiction in the family.
- Apply techniques for change at the individual and family levels using resilience and a strength-based model.
- Design a continuing care plan for families impacted by opioid addiction.
